Imerys (NK) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
21 Sep, 2026Executive summary
H1 2024 adjusted EBITDA rose 11% year-over-year to €384 million, with margin up 260 bps to 20%, supported by strong U.S. demand, cost controls, and three consecutive quarters of sequential growth.
Revenue for H1 2024 was €1,919 million, with Q2 volumes up 2.7% year-over-year and sequential growth, driven by volume gains and market share increases in the U.S.
Current net income from continuing operations, Group share, increased 25% to €173 million in H1 2024.
Completed disposal of paper market assets for ~€150 million in July 2024, streamlining the portfolio and eliminating exposure to graphic paper.
Disclosed a Climate Transition Plan, targeting significant GHG reductions by 2030, and renewed a biodiversity partnership.
Financial highlights
H1 2024 sales reached €1.9 billion, with Q2 revenue at €992 million (+0.7% year-over-year, +7% sequentially from Q1), and growth entirely volume-driven.
Adjusted EBITDA margin improved to 20% in H1 2024 (up from 17.4% in H1 2023), driven by volume recovery, €70 million in cost savings, and positive price-cost balance.
Net current free operating cash flow before strategic capex was €120 million; free operating cash flow was €88 million.
Net financial debt at June 30, 2024, was €1,232 million, with a net financial debt/adjusted EBITDA ratio of 1.7x.
Net income, Group share, for H1 2024 was €142 million, slightly below H1 2023 due to the absence of discontinued operations' contribution.
Outlook and guidance
Expects continued positive business momentum in H2 2024, targeting full-year adjusted EBITDA of €670–690 million, compared to €668 million in 2023 (which included divested paper assets).
Guidance assumes stable macroeconomic conditions and a significantly lower contribution from joint ventures in H2.
Anticipates ongoing recovery in traditional businesses and further improvement in graphite and carbon, while remaining prudent on high purity quartz due to inventory overhang.
Latest events from Imerys
- H1 2026 saw 1.8% revenue and 10% EBITDA growth, margin gains, and strong cash flow.NK
Q2 2026 - Stable results, €0.75 dividend, strategic focus on lithium, cost savings, and strong ESG progress.NK
AGM 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 2025 - Nine-month revenue fell 0.7% to €2,583m; EBITDA guidance and cost actions reaffirmed.NK
Q3 2025 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 2024 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 2025 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 2025 - Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 2024